Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000007668
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
AVONIX (AUTHORIZED: MULTIPLE SCLEROSIS)
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
||
|
WHO-VATC |
QL03AB07
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
95195
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
||
|
FDA ORPHAN DRUG |
69392
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
||
|
FDA ORPHAN DRUG |
111598
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
||
|
FDA ORPHAN DRUG |
63391
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
||
|
WHO-ATC |
L03AB07
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
||
|
FDA ORPHAN DRUG |
115498
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
||
|
NDF-RT |
N0000007956
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
REBIF (AUTHORIZED: MULTIPLE SCLEROSIS)
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
||
|
NDF-RT |
N0000007668
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
62791
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
||
|
NDF-RT |
N0000175747
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
62891
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
||
|
FDA ORPHAN DRUG |
53290
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
||
|
NDF-RT |
N0000007668
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8339
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
PRIMARY | |||
|
FF-5
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
PRIMARY | |||
|
m6305
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
PRIMARY | Merck Index | ||
|
145258-61-3
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
PRIMARY | |||
|
XRO4566Q4R
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
PRIMARY | |||
|
SUB12440MIG
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
PRIMARY | |||
|
1342412
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
ALTERNATIVE | |||
|
CHEMBL1201562
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
PRIMARY | |||
|
C086937
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
PRIMARY | |||
|
DB00060
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
PRIMARY | |||
|
8135
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
PRIMARY | |||
|
1342401
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
PRIMARY | |||
|
220581-49-7
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
ALTERNATIVE | |||
|
5139
Created by
admin on Sat Dec 16 00:10:42 GMT 2023 , Edited by admin on Sat Dec 16 00:10:42 GMT 2023
|
PRIMARY | |||
|
75917
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
PRIMARY | RxNorm | ||
|
C1823
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
PRIMARY | |||
|
INTERFERON BETA 1A
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
PRIMARY | |||
|
XRO4566Q4R
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
PRIMARY | |||
|
100000089299
Created by
admin on Sat Dec 16 00:10:43 GMT 2023 , Edited by admin on Sat Dec 16 00:10:43 GMT 2023
|
PRIMARY |
ACTIVE MOIETY